Melanoma Therapeutics Foundation


	About Us	What is Melanoma?	Drug Development Process	Patient Information	Join Us	Contact Us	Home

Melanoma Therapeutics Foundation - Patient Information

News & Updates

In the March 2007 issue of Start Up © – (Windhover Information Inc’s review of emerging medical ventures) - The Melanoma Therapeutics Foundation is recognized for its novel commitment to drug development. The Foundation’s approach is described as good news for patients, researchers and industry.

May 2008 - Former Executive Director of Melanoma Therapeutics Foundation and Ex-Bayer executive Wolf Busse aims at cancers such as Melanoma and launches ACT Biotech [read the article]
4 out of 5 sunscreens inadequate, study finds [read the article]
New treatment sends deadly melanoma into remission for one man [read the article]
PBS Program Explains DNA Testing for Hereditary Cancers [read the article]

Educational Links

American Society of Clinical Oncology http://www.asco.org

FDA, Food and Drug Administration http://www.fda.gov/

CEDR, Center for Drug Evaluation and Research http://www.fda.gov/cder/

NCI melanoma website http://www.cancer.gov/cancertopics/types/melanoma

MedlinePlus melanoma http://www.nlm.nih.gov/medlineplus/melanoma.html

American Cancer Society http://www.cancer.org/docroot/home/index.asp

Clinical Trials

For more information on clinical trials review the following links:

NCI clinical trials gateway http://www.cancer.gov/clinicaltrials

NIH clinical trials gateway http://clinicaltrials.gov/